Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions
Completed · Phase 2
Conditions studied: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
In brief
RATIONALE: Umbilical cord blood transplantation may allow doctors to give higher doses of chemotherapy or radiation therapy and kill more cancer cells. PURPOSE: This phase II trial is studying how well umbilical cord blood transplantation works in treating patients with severe aplastic anemia, malignant thymoma, or myelodysplasia.
Key facts
- Study ID
- NCT00003336
- Run by
- Case Comprehensive Cancer Center
- People needed
- 6
- Starts
- 1998-01-01
- Expected to finish
- 2006-02-01
- Last updated by the study team
- 2010-06-11
Who can join
Age: any, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.